FR2833838B1 - METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED - Google Patents

METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED

Info

Publication number
FR2833838B1
FR2833838B1 FR0116704A FR0116704A FR2833838B1 FR 2833838 B1 FR2833838 B1 FR 2833838B1 FR 0116704 A FR0116704 A FR 0116704A FR 0116704 A FR0116704 A FR 0116704A FR 2833838 B1 FR2833838 B1 FR 2833838B1
Authority
FR
France
Prior art keywords
tablet
manufacturing
morphinic
analgesic
morphinic analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0116704A
Other languages
French (fr)
Other versions
FR2833838A1 (en
Inventor
Saint Jean Catherine Lacaze
Sylvie Cuart
Laurent Terrassin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ellipse Pharmaceuticals SAS
Original Assignee
Ellipse Pharmaceuticals SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellipse Pharmaceuticals SAS filed Critical Ellipse Pharmaceuticals SAS
Priority to FR0116704A priority Critical patent/FR2833838B1/en
Priority to PCT/FR2002/004488 priority patent/WO2003053417A2/en
Priority to AU2002364675A priority patent/AU2002364675A1/en
Publication of FR2833838A1 publication Critical patent/FR2833838A1/en
Application granted granted Critical
Publication of FR2833838B1 publication Critical patent/FR2833838B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
FR0116704A 2001-12-21 2001-12-21 METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED Expired - Fee Related FR2833838B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0116704A FR2833838B1 (en) 2001-12-21 2001-12-21 METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED
PCT/FR2002/004488 WO2003053417A2 (en) 2001-12-21 2002-12-20 Method for making a tablet comprising a morphine type analgesic and resulting tablet
AU2002364675A AU2002364675A1 (en) 2001-12-21 2002-12-20 Method for making a tablet comprising a morphine type analgesic and resulting tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0116704A FR2833838B1 (en) 2001-12-21 2001-12-21 METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED

Publications (2)

Publication Number Publication Date
FR2833838A1 FR2833838A1 (en) 2003-06-27
FR2833838B1 true FR2833838B1 (en) 2005-09-16

Family

ID=8870863

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0116704A Expired - Fee Related FR2833838B1 (en) 2001-12-21 2001-12-21 METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED

Country Status (3)

Country Link
AU (1) AU2002364675A1 (en)
FR (1) FR2833838B1 (en)
WO (1) WO2003053417A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10361596A1 (en) 2003-12-24 2005-09-29 Grünenthal GmbH Process for producing an anti-abuse dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Anti-abuse dosage form
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102004032051A1 (en) 2004-07-01 2006-01-19 Grünenthal GmbH Process for the preparation of a secured against misuse, solid dosage form
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Break-resistant dosage forms with sustained release
DE102004032049A1 (en) * 2004-07-01 2006-01-19 Grünenthal GmbH Anti-abuse, oral dosage form
DE102005005449A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Process for producing an anti-abuse dosage form
SA07280459B1 (en) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic
TWI454288B (en) 2008-01-25 2014-10-01 Gruenenthal Chemie Pharmaceutical dosage form
SI2273983T1 (en) 2008-05-09 2016-11-30 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
JP5667183B2 (en) 2009-07-22 2015-02-12 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Controlled release dosage form with heat melt extrusion
JP2012533585A (en) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Tamper-resistant dosage forms for oxidation-sensitive opioids
ES2486791T3 (en) 2010-09-02 2014-08-19 Grünenthal GmbH Tamper resistant dosage form comprising an inorganic salt
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
AR087360A1 (en) 2011-07-29 2014-03-19 Gruenenthal Gmbh PROOF OF HANDLING TABLET PROVIDING IMMEDIATE RELEASE OF PHARMACY
US20130028972A1 (en) 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
BR112014019988A8 (en) 2012-02-28 2017-07-11 Gruenenthal Gmbh BREAK-RESISTANT DOSAGE FORM COMPRISING A PHARMACOLOGICALLY ACTIVE COMPOUND AND AN ANIONIC POLYMER
ES2692944T3 (en) 2012-04-18 2018-12-05 Grünenthal GmbH Pharmaceutical dosage form resistant to handling and resistant to rapid discharge of the dose
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014191396A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
BR112015026549A2 (en) 2013-05-29 2017-07-25 Gruenenthal Gmbh tamper-proof dosage form containing one or more particles
CN105682643B (en) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 Tamper resistant dosage form containing ethylene-vinyl acetate polymer
CA2931553C (en) 2013-11-26 2022-01-18 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
AU2015261060A1 (en) 2014-05-12 2016-11-03 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising Tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
MX2017013637A (en) 2015-04-24 2018-03-08 Gruenenthal Gmbh Tamper-resistant dosage form with immediate release and resistance against solvent extraction.
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10014588A1 (en) * 2000-03-27 2001-10-04 Basf Ag Sustained-release oral dosage form that floats in gastric fluid includes a blend of polyvinyl acetate and polyvinylpyrrolidone

Also Published As

Publication number Publication date
FR2833838A1 (en) 2003-06-27
WO2003053417A3 (en) 2003-12-18
AU2002364675A1 (en) 2003-07-09
WO2003053417A2 (en) 2003-07-03
AU2002364675A8 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
FR2833838B1 (en) METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED
FR2812449B1 (en) PLASMA DISPLAY AND METHOD FOR MANUFACTURING PLASMA DISPLAY
FR2825834B1 (en) METHOD FOR MANUFACTURING A SEMICONDUCTOR DISSIVE
FR2847155B1 (en) METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY
BR0207423B1 (en) "APPARATUS AND METHOD FOR SMALL COMPACTING A WELL PRODUCTION INTERVAL"
FR2777690B1 (en) STRUCTURE AND METHOD FOR MANUFACTURING A CAPACITOR
FR2798220B1 (en) INDUCTANCE AND MANUFACTURING METHOD
FR2806831B1 (en) METHOD FOR MANUFACTURING A BIPOLAR SELF-ALIGNED DOUBLE-POLYSILICIUM TYPE BIPOLAR TRANSISTOR AND CORRESPONDING TRANSISTOR
FR2805331B1 (en) MULTICHANNEL ELEMENT AND METHOD FOR MANUFACTURING SUCH AN ELEMENT
FR2858618B1 (en) PROCESS AND REACTOR FOR MANUFACTURING HYDROXYMETHYLFURFURAL
FR2836242B1 (en) PROCESS FOR MANUFACTURING A PROJECTION SCREEN
FR2860445B1 (en) METHOD FOR MANUFACTURING A MOLD AND MOLD OBTAINED
FR2822597B1 (en) MULTI-OBJECT COMMON USE CONNECTOR AND METHOD FOR MANUFACTURING THE CONNECTOR
FR2779747B1 (en) METHOD FOR MANUFACTURING A KNITTED ARTICLE AND ARTICLE SO OBTAINED
FR2856189B1 (en) METHOD FOR MANUFACTURING A MAGNETIC ENCODING DEVICE, AND THE DEVICE THUS OBTAINED
FR2822292B1 (en) METHOD FOR MANUFACTURING A DOUBLE POLYSILICON-TYPE BIPOLAR TRANSISTOR HETEROJUNCTION BASED AND CORRESPONDING TRANSISTOR
FR2842137B1 (en) METHOD FOR MANUFACTURING A BELOW BELLOW
FR2796577B1 (en) PROCESS FOR MANUFACTURING A TUBULAR ELEMENT AND TUBULAR ELEMENT THUS OBTAINED
FR2837216B1 (en) METHOD FOR MANUFACTURING A MOLDED ELEMENT
FR2827294B1 (en) DISCONTINUOUS PROCESS FOR THE MANUFACTURE OF A POLYAMIDE
FR2809657B1 (en) METHOD FOR MANUFACTURING FURNITURE ELEMENT
FR2808031B1 (en) METHOD OF OPERATING A GRAVILLONNEUR AND GRAVILLONNEUR OBTAINED
FR2834377B1 (en) ANTI-DIFFUSING GRID AND METHOD FOR MANUFACTURING SUCH A GRID
FR2806948B1 (en) PROCESS FOR MANUFACTURING A METAL LOT
FR2829909B1 (en) METHOD FOR MANUFACTURING A PREFORMED MODULE FOR A THERMOFORMED SOLE, PREFORMED MODULE AND A THERMOFORMED SOLE

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060831